CLSI H43 A2 : 2ED 2007
Current
The latest, up-to-date edition.
CLINICAL FLOW CYTOMETRIC ANALYSIS OF NEOPLASTIC HEMATOLYMPHOID CELLS
Hardcopy , PDF
English
23-04-2007
Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Overview
4.1 Goals
4.2 Quality Control Procedures
4.3 Sample Preparation
4.4 Reagents
4.5 Data Acquisition
4.6 Data Analysis and Interpretation
5 Terminology
5.1 Definitions
5.2 Acronyms and Abbreviations
6 Safety
6.1 Specimen Collection
6.2 Safety Attire
6.3 Biological Safety Cabinets
6.4 Sample Containers
6.5 Centrifugation
6.6 Pipetting
6.7 Sharp Devices
6.8 Blood Spills
6.9 Waste Disposal and Specimen Inactivation
6.10 Specimen Storage
6.11 Unfixed Specimens
6.12 Equipment Disinfection
7 Specimen Collection
7.1 Labeling of Specimen and Test Requisition
7.2 Sample Collection Techniques
7.3 Anticoagulants
8 Specimen Transport
8.1 Specimen Handling and Packaging
8.2 Specimen Integrity
9 Sample Preparation
9.1 Visual Inspection
9.2 Selection of a Sample Preparation Procedure
9.3 Adjustment of Cell Counts
9.4 Evaluation of Sample Viability
9.5 Sample Preparation for Immunoglobulin Staining
9.6 Intracellular Sample Preparation
10 Immunofluorescence Staining of Surface and Intracellular
Antigens in Neoplastic Hematolymphoid Specimens
10.1 Reagents
10.2 Optimization of Staining Protocol
11 Sample Quality Control
11.1 Verification of a Neoplastic Hematolymphoid Population
11.2 Negative Controls
11.3 Positive Controls
12 Data Acquisition
12.1 Instrument Configuration
12.2 Enrichment for Cells of Interest
12.3 Analysis of Negative Control Sample(s)
12.4 Data Management
12.5 Consistency in Data
13 Data Analysis
13.1 Goals
13.2 Identification and Analysis of Populations in
Specimens
13.3 Quantification of Antigen Expression
13.4 Multiparametric Analysis
14 Data Reporting and Interpretation
14.1 Introduction
14.2 Acute Leukemia
14.3 Mature Lymphoid Neoplasms
14.4 Myelodysplastic Syndrome (MDS)
14.5 Data Reporting
14.6 Regulatory Statement
15 Data Storage
15.1 Information Stored
15.2 Types of Data Storage
References
Additional References
Appendix A. Instrument Setup and Quality Control of
Instrument Performance
References for Appendix A
Summary of Delegate Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI/NCCLS Publications
Provides performance guidelines for the immunophenotypic analysis of neoplastic hematolymphoid cells using immunofluorescence-based flow cytometry; for sample and instrument quality control; and precautions for acquisition of data from neoplastic hematolymphoid cells.
DevelopmentNote |
Supersedes NCCLS H43 A. (04/2007)
|
DocumentType |
Miscellaneous Product
|
ISBN |
1-56238-635-2
|
Pages |
96
|
PublisherName |
Clinical Laboratory Standards Institute
|
Status |
Current
|
Supersedes |
CLSI H42 A2 : 2ED 2007 | ENUMERATION OF IMMUNOLOGICALLY DEFINED CELL POPULATIONS BY FLOW CYTOMETRY |
CLSI H52 A2 : 2ED 2014 | Red Blood Cell Diagnostic Testing Using Flow Cytometry; Approved Guideline—Second Edition |
CLSI H3 A5 : 5ED 2003 | PROCEDURES FOR THE COLLECTION OF DIAGNOSTIC BLOOD SPECIMENS BY VENIPUNCTURE |
CLSI M29 A3 : 3ED 2005 | ACQUIRED INFECTIONS; APPROVED GUIDELINE |
CLSI H20 A2 : 2ED 2007 | Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods, 2nd Edition<br> |
CLSI I/LA24 A : 1ED 2004 | FLUORESCENCE CALIBRATION AND QUANTITATIVE MEASUREMENT OF FLUORESCENCE INTENSITY |
CLSI H26 A : 1ED 96 | PERFORMANCE GOALS FOR THE INTERNAL QUALITY CONTROL OF MULTICHANNEL HEMATOLOGY ANALYZERS |
CLSI H1 A5 : 5ED 2003 | TUBES AND ADDITIVES FOR VENOUS BLOOD SPECIMEN COLLECTION |
CLSI H18 A3 : 3ED 2004 | PROCEDURES FOR THE HANDLING AND PROCESSING OF BLOOD SPECIMENS |
CLSI GP5 A2 : 2ED 2002 | CLINICAL LABORATORY WASTE MANAGEMENT |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.